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Abstract
Pancreatic acinar-to-ductal metaplasia (ADM) is associated with an increased risk of pancreatic cancer and is considered a
precursor of pancreatic ductal adenocarcinoma. Transgenic expression of transforming growth factor alpha (TGF-a)o rK -
ras
G12D in mouse pancreatic epithelium induces ADM in vivo. Protein kinase C iota (PKCi) is highly expressed in human
pancreatic cancer and is required for the transformed growth and tumorigenesis of pancreatic cancer cells. In this study,
PKCi expression was assessed in a mouse model of K-ras
G12D-induced pancreatic ADM and pancreatic cancer. The ability of
K-ras
G12D to induce pancreatic ADM in explant culture, and the requirement for PKCi, was investigated. PKCi is elevated in
human and mouse pancreatic ADM and intraepithelial neoplastic lesions in vivo. We demonstrate that K-ras
G12D is sufficient
to induce pancreatic ADM in explant culture, exhibiting many of the same morphologic and biochemical alterations
observed in TGF-a-induced ADM, including a dependence on Notch activation. PKCi is highly expressed in both TGF-a- and
K-ras
G12D-induced pancreatic ADM and inhibition of PKCi significantly reduces TGF-a- and K-ras
G12D-mediated ADM.
Inhibition of PKCi suppresses K-ras
G12D–induced MMP-7 expression and Notch activation, and exogenous MMP-7 restores K-
ras
G12D–mediated ADM in PKCi-depleted cells, implicating a K-ras
G12D-PKCi-MMP-7 signaling axis that likely induces ADM
through Notch activation. Our results indicate that PKCi is an early marker of pancreatic neoplasia and suggest that PKCi is a
potential downstream target of K-ras
G12D in pancreatic ductal metaplasia in vivo.
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Introduction
Oncogenic KRAS mutations are found in .90% of pancreatic
ductal adenocarcinomas (PDACs). [1] Mutational activation of
KRAS is thought to occur early in PDAC development, as KRAS
mutations are observed in ,30% of PDAC precursor lesions,
pancreatic intraepithelial neoplasia (PanIN). [1] A mouse model
for conditional expression of an activated Kras (Kras
G12D) allele in
the pancreas from its physiological promoter has been utilized to
investigate the role of oncogenic K-ras in initiation and
progression of PDAC. [2,3,4] Expression of oncogenic K-ras
induces formation of preneoplastic lesions in mice that are
histologically similar to human PanINs (mouse PanINs, mPanINs).
[2,4] K-ras
G12D–induced mPanINs become increasingly dysplas-
tic, with a small percent progressing to invasive and metastatic
adenocarcinomas, strongly suggesting that acquisition of an
oncogenic Kras mutation can be an initiating event in pancreatic
cancer. [2,4]
Acinar-to-ductal metaplasia (ADM), the replacement of acinar
cells with metaplastic ductal cells, is thought to be a source of
neoplasia in the initiation of human PDAC. [4,5,6] Dysplastic
features often arise in areas of ductal metaplasia, and metaplastic
ductal cells exhibit many properties of embryonic progenitor cells,
including Nestin expression. [4,7,8] The K-ras
G12D-initiated
mouse model of PDAC exhibits morphological, molecular and
biochemical features indicative of ADM as early as 4 weeks of age,
prior to the development of mPanINs. [2,4] Aberrant activation of
EGFR signaling in mouse pancreas also induces ADM and
subsequent formation of PDAC. [7,9,10] EGFR-mediated ADM
has been further characterized in an explant model. [11,12] TGF-
a induces primary mouse pancreatic acinar cells to transition
through a de-differentiated, Nestin-positive intermediate to form
metaplastic ductal structures. [7,11,12] Additional studies revealed
that Notch signaling is both necessary and sufficient for acinar cell
de-differentiation, Nestin expression and ADM in explant culture.
[2,12] MMP-7, which is also upregulated in human and mouse
PanINs and PDAC, promotes activation of Notch signaling and
ADM. [13,14] MMP-7 is required for ADM in explant culture,
and expression of a constitutively active Notch construct
reconstitutes ADM in MMP-7–depleted acinar cells, indicating
that MMP-7-dependent Notch activity is required for ADM. [14]
These studies demonstrate the utility of the pancreatic acinar cell
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link between pancreatic metaplasia, neoplasia and initiation of
PDAC.
We have identified PKCi as an important effector in oncogenic
K-ras-induced transformation of lung and intestinal epithelial cells.
[15,16] We have also demonstrated that PKCi expression is
elevated in a large percent of primary pancreatic adenocarcino-
mas, and high PKCi expression predicts poor patient survival.
[17] In the current study, we demonstrate that PKCi is elevated in
pancreatic metaplasia associated with human PDAC tumors and
in K-ras
G12D-mediated pancreatic metaplasia in vivo. To further
characterize the molecular mechanism of K-ras
G12D-mediated
pancreatic ADM we employed a well-characterized mouse
pancreatic acinar cell explant model. In this context, we evaluated
the role of PKCi in K-ras
G12D-mediated pancreatic ADM.
Expression of oncogenic K-ras, the most frequently mutated
oncogene in PDAC, is sufficient to induce pancreatic ADM in
explant culture. PKCi expression is elevated in K-ras
G12D- and
TGFa-induced ADM. Inhibition of PKCi significantly reduces
both K-ras
G12D- and TGFa-induced ADM and also significantly
reduces K-ras
G12D-mediated Nestin expression, Notch activation
and MMP-7 expression. Exogenous MMP-7 partially but
significantly reconstitutes K-ras
G12D-mediated ADM in PKCi-
depleted cells, suggesting that PKCi mediates initiation of ADM,
at least in part, by regulating MMP-7 expression. Our results
demonstrate that K-ras
G12D-mediated ADM in explant culture is
regulated by PKCi.
Results
PKCi is induced in oncogenic K-ras-mediated ADM in vivo
PKCi expression is elevated in the vast majority of primary
PDAC, and high PKCi expression predicts poor patient survival.
[17] PKCi is also elevated in PanINs and pancreatic metaplastic
ducts associated with human PDAC (Figure 1A). In normal
mouse pancreas, PKCi is detected in interlobular ductal cells, but
not in acinar cells (Figure 1B). PKCi expression was also detected
in mPanINs (Figure 1C) from P48-Cre;LSL-Kras mice. PKCi
expression tended to increase, with a redistribution from apical to
cytoplasmic localization, in more progressed mPanIN lesions and
in adenocarcinoma (Figure S1). Interestingly, PKCi was also
expressed in the metaplastic ductal cells, but not in the
morphologically normal acinar cells of K-ras
G12D-induced ADM
(Figure 1D). K-ras
G12D-induced pancreatic ADM exhibits some
of the same properties of mPanINs, including increased prolifer-
ation and Notch signaling, [2,4,11,12,14] suggesting ADM is a
precursor to mPanINs and therefore relevant to the initiation of
PDAC. [4] The increased PKCi expression observed in K-
ras
G12D-induced ADM prompted us to investigate a possible role
for PKCi in K-ras
G12D-induced ADM using an explant culture
amenable to evaluation of the molecular mechanisms involved in
the specific transdifferentiation of pancreatic acinar cells to
metaplastic duct-like cells.
PKCi regulates TGF-a-mediated ADM
As described, mouse pancreatic acinar cells plated in collagen
matrix undergo TGF-a-induced ADM, characterized by morpho-
logical conversion from clusters of zymogen-containing acinar cells
to cystic structures with a ductal morphology (Figure S2A).
[11,14] This morphological transformation is associated with a loss
of acinar differentiation, as assessed by amylase expression and a
concomitant increase in ductal differentiation, characterized by
expression of cytokeratin 19 (CK-19) (Figure S2B). [11] PKCi
expression is undetectable in isolated acinar cells, but is
significantly increased as cells undergo TGF-a-induced ADM
(Figure 2A), consistent with PKCi playing a role in the
transdifferentiation of pancreatic acinar cells to metaplastic ducts.
To investigate the role of PKCi in TGF-a-mediated ADM, we
utilized pancreatic acinar cells isolated from Prkci
f/f mice. [18]
Prkci
f/f acinar cells were transduced with control adeno-virus
(adeno-null) or adeno-virus expressing Cre-recombinase (adeno-
Cre) to induce genetic recombination and deletion of the loxP-
flanked Prkci allele (Figure S3A). Adeno-null-treated Prkci
f/f
acinar cells underwent ADM in response to TGF-a,w h i l e
adeno-Cre-treated Prkci
f/f acinar cells were largely refractory to
TGF-a-induced ADM (Figure 2B). Adeno-Cre treatment did
not inhibit TGF-a-mediated ADM in R26R acinar cells (Figure
S3B and C). Consistent with a specific requirement for PKCi,
addition of the molecularly-targeted inhibitor of PKCi signaling,
aurothiomalate, [19,20,21] to the explant culture significantly
reduced TGF-a-induced ADM (Figure 2C). These data
demonstrate at least a partial requirement for PKCi for TGF-
a-induced ADM.
K-ras
G12D induces ADM in explant culture
The earliest morphological alteration observed in the pancreata
of P48-Cre;LSL-Kras mice is the formation of metaplastic structures
containing both acinar- and duct-like cells. [4] Molecular analysis
of these metaplastic structures suggests that K-ras
G12D induces
ADM. [4] To evaluate the role of PKCi in K-ras
G12D-induced
ADM, we first characterized the ability of K-ras
G12D to induce
ADM in explant culture. Pancreatic acinar cells were isolated from
LSL-Kras mice and incubated with adeno-Cre-GFP to induce
genomic recombination (Figure S4A) and expression of K-
ras
G12D. K-ras
G12D was sufficient to induce ADM in explant
culture in the absence of exogenous TGF-a, as determined by
transition from acinar to ductal morphology (Figure 3A) with a
single layer of cells surrounding a clear lumen, indicative of a
mature ductal structure (Figure S4B). Likewise, a loss of
expression of acinar cell markers and a gain of expression of
ductal cell markers was also observed in K-ras
G12D–induced ADM
(Figure 3B and Figure S4C) confirming transition from acinar
to ductal gene expression profile.
While K-ras
G12D induced ADM in explant culture in the
absence of exogenous TGF-a, TGF-a mRNA was elevated in K-
ras
G12D–mediated ADM (Figure 3C). K-ras
G12D–induced ADM
was partially, but significantly reduced by Erlotinib, an EGFR
inhibitor (Figure 3D). Furthermore, inhibition of Rac1 blocks K-
ras
G12D-mediated ADM (Figure 3D), consistent with a recent
report that Rac1 activity regulates ADM. [22] K-ras
G12D-induced
ADM was also accompanied by a significant increase in PKCi
expression (Figure 3E) in CK-19-positive duct cells (Figure
S4D). Taken together, these results demonstrate that K-ras
G12D
induces metaplastic duct formation in explant culture, as in mouse
pancreas in vivo, [4] and that PKCi expression is induced in K-
ras
G12D-mediated metaplastic ducts in vitro and in vivo.
PKCi regulates K-ras
G12D-induced ADM
We next tested the hypothesis that PKCi plays a role in K-
ras
G12D-induced ADM in explant culture, using acinar cells from
LSL-Kras;Prkci
f/f mice which allow simultaneous Cre-mediated
activation of expression of K-ras
G12D and genetic knockout of
PKCi. [16] K-ras
G12D induced ADM in LSL-Kras acinar cells, but
not LSL-Kras;Prkci
f/f acinar cells (Figure 4A, B). Expression of
PKCi and CK-19 remained low in adeno-Cre-GFP-treated LSL-
Kras;Prkci
f/f explant cultures, compared to adeno-Cre-GFP-treated
LSL-Kras explant cultures (compare Figure S5A to Figure S4D).
GFP expression confirmed highly efficient viral infection of both
K-ras
G12D Induces ADM in Acinar Explant Culture
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f/f acinar cells (Figure S5B) and PCR
analysis demonstrated adeno-Cre-mediated recombination of both
the LSL-Kras and Prkci
f/f floxed alleles in the LSL-Kras;Prkci
f/f acinar
cells (Figure S5C). Furthermore, addition of aurothiomalate to
the explant culture also significantly reduced K-ras
G12D-mediated
ADM (Figure 4C), without a significant effect on cell viability
(data not shown). aurothiomalate did not prevent K-ras
G12D-
induced PKCi expression (Figure S5D and E), however, PKCi
was detected primarily in the cytoplasm of aurothiomalate-blocked
acinar-like cells, in contrast to the more basolateral localization of
PKCi in K-ras
G12D-induced metaplastic ducts (Figure S5D).
Therefore, genetic and pharmacological inhibition of PKCi
significantly reduce K-ras
G12D-mediated ADM, strongly support-
ing a role for PKCi activity in K-ras
G12D-mediated ADM.
Figure 1. PKCi expression is elevated in PanINs and pancreatic metaplastic ducts. A) Immunohistochemical detection of PKCi (brown) in
formalin-fixed human pancreatic tumor-associated PanIN (left) and metaplastic ducts (right). Arrowhead=PanIN (left), metaplastic duct (right);
Arrow=cell with acinar morphology. B) Immunohistochemical detection of PKCi (brown) and CK19 (brown) in serial sections of WT mouse pancreas.
H&E staining demonstrates tissue morphology. Arrowhead=pancreatic duct, Arrow=normal acinar cells. C, D) Immunohistochemical detection of
PKCi and CK19 expression in serial sections of pancreatic epithelium of a P48-Cre;LSL-Kras mouse. [2] H&E staining demonstrates tissue morphology.
Arrows=cells with acinar morphology; Arrowheads=K-ras
G12D-induced C) mPanINs or D) metaplastic ducts. Scale bars, 100 mm.
doi:10.1371/journal.pone.0030509.g001
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Nestin-positive intermediate in K-ras
G12D-expressing
acinar cells
TGF-a-induced ADM proceeds through a de-differentiated,
Nestin-positive intermediate that requires activation of Notch.
[11,12,14] We asked whether K-ras
G12D-induced ADM also
proceeds through a Nestin-positive intermediate. Nestin expres-
sion was undetectable in K-ras
G12D-expressing explant cultures on
day 1, but increased significantly by day 3 (Figure 5), similar to
the kinetics of Nestin expression in TGFa-induced ADM.
[11,12,14] PKCi ablation blocked K-ras
G12D-induced Nestin
expression on day 3 (Figure 5), implicating PKCi in the initial
de-differentiation step of K-ras
G12D-induced ADM.
Notch signaling is activated in K-ras
G12D-mediated ADM in
vivo, [4] and is both required and sufficient to induce pancreatic
ADM in explant culture. [12] We therefore evaluated whether
Notch was activated by K-ras
G12D in explant culture (Figure 6).
Gamma-secretase-dependent cleavage of the Notch receptor is
required for activation of Notch signaling. [23] Using an antibody
specific for gamma-secretase cleaved (activated) Notch1, we
detected little to no activated Notch1 in K-ras
G12D-expressing
acinar cell explant culture on day 1, but by day 3 the amount of
activated Notch was significantly increased (Figure 6A). K-
ras
G12D-induced Notch1 activation was inhibited in PKCi–
deficient cells (Figure 6A). Likewise, expression of Hes1, a Notch
transcriptional target, was induced in K-ras
G12D-expressing
explant culture, but the increased Hes1 expression was blocked
by loss of PKCi expression (Figure 6B), implicating PKCi in the
regulation of Notch1 activation. Finally, K-ras
G12D-induced ADM
was significantly reduced by a gamma-secretase inhibitor (L-
685,458)[24] (Figure 6C), suggesting that K-ras
G12D-induced
ADM may require Notch activity.
MMP-7 overcomes PKCi deficiency to recover ADM
Our data strongly suggest that PKCi regulates acinar-to-ductal
transdifferentiation prior to Notch activation. Sawey et al.
demonstrated that MMP-7 is both necessary and sufficient for
Notch activation in ADM in explant culture. [14] MMP-7
expression is elevated in K-ras
G12D-induced mPanINs in vivo,
suggesting a role for MMP-7 in K-ras
G12D-initiated neoplasia. [2]
Consistent with these findings, we found that K-ras
G12D-induced
ADM was accompanied by a significant increase in MMP-7
expression, whereas PKCi-null explants showed no induction of
MMP-7 (Figure 7A). Genetic knockout of PKCi expression in K-
ras
G12D-expressing explant culture significantly reduced the K-
ras
G12D-induced increase in MMP-7 mRNA expression (Figure
S6A), suggesting that PKCi may regulate MMP-7 transcription.
To test whether restoration of MMP-7 rescues K-ras
G12D-induced
ADM in PKCi-deficient acinar cells, we added recombinant
MMP-7 to the explant culture. Indeed, MMP-7 significantly
enhanced ADM in PKCi-deficient cells (Figure 7B, C). PKCi
expression remains low in MMP-7-induced ducts (compare
Figure S6B to Figure S5A), suggesting that addition of
exogenous MMP-7 by-passes PKCi in promoting ADM, and
providing support for the hypothesis that PKCi regulates ADM, at
least in part, by controlling MMP-7 expression. [14] The lack of
Figure 2. PKCi regulates TGF-a-induced formation of metaplastic ducts. WT pancreatic acinar cells were embedded in collagen matrix with
50 ng/ml TGF-a. A) PKCi immunofluorescence (red) in explant cultures on days 1, 3, 5 and 7. PKCi was detected in ductal cells but not acinar cells.
Cells were co-stained with DAPI (blue) to define cell nuclei. Scale bar, 50 mm. B–C) Quantitative analysis of TGF-a-induced duct formation in
pancreatic explants in which PKCi is genetically or pharmacologically inhibited. B) Pancreatic acinar cells were isolated from Prkci
f/f mice, incubated
with control, adeno-null virus (Ad-null) or adeno-Cre virus (Ad-Cre) and embedded in collagen 6 TGF-a for 7 days. C) Pancreatic acinar cells isolated
from WT mice were embedded in collagen 6 TGFa and 6100 mM aurothiomalate (ATM) for 7 days. Plots are an average of three independent
experiments. Bars=mean 6 SEM and *P,.05 versus TGF-a-treated control wells.
doi:10.1371/journal.pone.0030509.g002
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acinar cells may be due to the reduced diffusion of MMP-7 in
collagen matrix, but may also indicate the requirement of
additional factors downstream of PKCi. Our results demonstrate
that K-ras
G12D-induced ADM utilizes signaling pathways impli-
cated in TGF-a-induced ADM in explant culture and K-ras
G12D-
induced pancreatic carcinogenesis in vivo. [2,4,25] Importantly, we
make the novel observation that PKCi regulates K-ras
G12D- and
TGF-a-mediated pancreatic ADM in explant culture.
Discussion
PKCi is highly overexpressed in human pancreatic cancer and
expression of PKCi-targeted RNAi significantly reduces PDAC
cell transformed growth and tumorigenicity in vivo. [17] These data
suggest that PKCi plays a required role in human pancreatic
cancer. We have previously defined a required role for PKCi in
oncogenic K-ras-mediated initiation of preneoplastic lesions of the
lung and intestinal epithelium. [15,16] In this study, we
investigated the role of PKCi in oncogenic K-ras signaling and
initiation of pancreatic metaplasia using a well-characterized
pancreatic explant culture model.
Increasing evidence suggest that PanINs can develop from
acinar cells and that ADM may be a critical intermediate in the
development of PanINs. [4,26] PKCi expression is significantly
higher in K-ras
G12D-mediated ductal metaplasia than in morpho-
logically normal regions of mouse pancreatic acinar cells, and
remains elevated in mPanINs and adenocarcinoma. To directly
investigate the role of PKCi in K-ras
G12D-mediated ADM, we
utilized an acinar cell explant model of ADM [11] in which TGF-
a induces acinar cell de-differentiation to Nestin-positive,
precursor-like intermediates that subsequently convert to cytoker-
atin-expressing metaplastic ducts. [12,14] Indeed, several studies
have concluded that the rate limiting step in K-ras
G12D-mediated
mPanIN formation appears to be de-differentiation of mature
pancreatic exocrine cells. For example, creating an expanded, de-
differentiated cell population through genetic knockout of Mist1
(an acinar cell-restricted transcription factor) or pancreatic injury,
enhanced the rate of formation of K-ras
G12D-mediated mPanINs.
[27,28] Likewise, targeting K-ras
G12D only to Nestin-expressing
progenitor cells yielded similar levels of mPanINs as targeting the
entire exocrine cell population, [3] suggesting that this de-
differentiated, progenitor-like population of cells may be the
target for K-ras
G12D-mediated initiation of PDAC.
Figure 4. PKCi regulates K-ras
G12D-induced ADM. A, B) Pancreatic acinar cells from LSL-Kras and LSL-Kras;Prkci
f/f mice were incubated with Ad-
null or Ad-Cre and embedded in collagen. Cultures were A) photographed on day 7 (Scale bar, 200 mm) and B) quantified for metaplastic duct
formation. C) Pancreatic acinar cells from P48-Cre;LSL-Kras mice were embedded in collagen 6 100 mM aurothiomalate (ATM). B, C) Quantitative




G12D induces ADM in explant culture. Pancreatic acinar cells were isolated from LSL-Kras mice, incubated with adeno-Cre-GFP
virus, and embedded in collagen (without exogenous TGF-a). A) Representative bright field and fluorescent images were captured on days 1, 3 and 7.
GFP fluorescence indicates infection by adeno-Cre-GFP virus. Scale bar, 200 mm. B) ADM was confirmed by co-immunofluorescence of amylase (red)
and CK-19 (green) in K-ras
G12D–induced ductal cells on day 7. C) mRNA was isolated from day 1 and 6 explant cultures of Ad-Cre virus-treated LSL-Kras
acinar cells and analyzed by qPCR for TGF-a expression. Data is presented relative to 18S abundance (610
5) and is representative of two independent
experiments. D) Pancreatic acinar cells were isolated from LSL-Kras mice, incubated with Ad-Cre and embedded in collagen 6 1 mMo r1 0mM
Erlotinib, or 10 mM NSC23766 for 5 days. Quantitative analysis of metaplastic duct formation is plotted for each treatment. Bars=mean 6 SD. *P,0.05
(Student T-test). Plots are representative of two independent experiments. E) PKCi (red) was undetectable in LSL-Kras explant culture on day 1, but
was elevated in K-ras
G12D–induced ductal cells on day 7. Scale bar, 25 mm.
doi:10.1371/journal.pone.0030509.g003
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G12D induces ADM in
explant culture in a manner similar to TGF-a-induced ADM,
including progression through a Nestin-positive intermediate and
a dependence on PKCi. Inhibition of PKCi significantly reduced
K-ras
G12D-induced Nestin expression, suggesting a role for PKCi
in K-ras
G12D-mediated de-differentiation of mature acinar cells.
K-ras
G12D-induced ADM does not require exogenous TGF-a,
however, activation of K-ras
G12D induced TGF-a mRNA
expression and inhibition of EGFR decreased K-ras
G12D–induced
ADM in explant culture. Since EGFR expression and activation is
induced in K-ras
G12D–induced ADM in vivo [4] our data suggests
that K-ras
G12D may induce ADM, at least in part by up-regulation
of autocrine EGFR signaling. This hypothesis is supported by the
observation that EGFR signaling synergizes with K-ras
G12D to
promote progression of mPanINs in the LSL-Kras mouse model of
pancreatic cancer. [29]
The Notch signaling pathway, which blocks pancreatic acinar
cell differentiation and maintains cells in a non-differentiated,
proliferative state, is required for normal pancreatic development.
[30] Notch signaling is aberrantly reactivated in PanINs and
PDAC, as well as K-ras
G12D-initiated mPanINs. [12,31] These
observations suggest a required role for Notch signaling in K-
ras
G12D-mediated initiation of PDAC. Notch signaling is activated
by TGF-a in mouse pancreas in vivo and in explant culture, and
Notch signaling is required and sufficient for TGF-a-induced
ADM in explant culture. [12,14] K-ras
G12D also induces Notch
activation in acinar cell explant culture, and K-ras
G12D-mediated
ADM is significantly reduced by a gamma-secretase inhibitor,
suggesting that K-ras
G12D-mediated ADM may require Notch
activation. Inhibition of gamma-secretase activity, which blocks
activation of Notch signaling, inhibits progression of K-ras-
mediated mPanINs in vivo and reduces the transformed growth
of pancreatic cancer cells. [25,32] Likewise, expression of a
constitutively-active Notch promoted formation and progression of
K-ras-mediated mPanINs, suggesting a tumor-promotive role for
Notch signaling in the mouse model of PDAC. [26] Conversely,
genetic knockout of Notch1 expression promoted formation and
progression of K-ras-mediated mPanINs, suggesting that under
some conditions, or at certain stages of cancer development, Notch
signaling may suppress pancreatic cancer. [33] In this context, it
will be interesting to determine whether PKCi regulates Notch
activation in mPanINs and PDAC, since PKCi remains elevated
as mPanINs become increasingly dysplastic.
Inhibition of PKCi significantly reduced K-ras
G12D-mediated
MMP-7 expression, Notch activation and ADM in explant culture.
Addition of exogenous MMP-7 to the explant culture partially, but
significantly, recovered the inhibitory effect of PKCi deficiency.
These results implicate MMP-7 as a likely downstream effector of
PKCi in K-ras
G12D-mediated ADM, and a possible mechanism by
which PKCi regulates Notch1 activation, since MMP-7 can cleave
and activate Notch1 in metaplastic acinar cells. [14]
PKCi is required for mutant Apc-induced intestinal adenoma
formation. [34] Tumorigenesis in the Apc
min/+ mouse model also
requires MMP-7 and Notch activation. [35,36] MMP-7 has been
identified as a target gene of Rac1 in colorectal carcinoma cells, [37]
suggesting regulation of Rac1 activity as a possible mechanism by
which PKCi may regulate MMP-7 expression and initiation of
pancreatic and colon cancer. In addition, PKCi regulates expression
of another MMP, MMP-10, in lung cancer cells. [38] Both PKCi
and MMP-10 are required for lung cancer cell transformed growth,
[38,39] suggesting that regulation of expression of MMPs may be a
general mechanism by which PKCi controls initiation and
maintenance of the transformed phenotype in cancer.
In this study, we use both genetic and pharmacological means to
demonstrate that PKCi regulates TGF-a- and K-ras
G12D-induced
ADM in explant culture. Our results indicate that PKCi is an early
marker of pancreatic neoplasia. Our results further suggest that K-
ras
G12D-mediated ADM utilizes a PKCi-MMP-7 signaling path-
way, and that, similar to lung and colon cancer, [15,16] PKCi may
play a promotive role in the initiationof PDAC. Tri-transgenic P48-
Cre;LSL-Kras;Prkci
f/f mice would be useful to test the hypothesis that
PKCi is required for K-ras
G12D-mediated ADM and mPanIN
formation in vivo. However, these tri-transgenic mice are currently
unavailable due to difficulties in breeding. Overcoming these
breeding difficulties, whose cause is currently unknown, will be
important for future studies to test the prediction of our in vitro
results, namely, that PKCi plays a role in K-ras
G12D-mediated
pancreatic metaplasia and carcinogenesis in vivo.
Materials and Methods
Ethics Statement
Biospecimens were obtained from the Mayo Clinic SPORE in
Pancreatic Cancer Tissue Core under an approved Mayo Clinic
Institutional Review Board protocol (08-001607). All animal
experiments performed were approved by the Mayo Clinic
Institutional Animal Care and Use Committee (Mayo Clinic
Institutional Animal Care and Use Committee protocols A6508,
A48510).
Reagents
A list of antibodies used in this study and their sources can be
found in Table S1. Other reagents utilized: recombinant human
Figure 5. Inhibition of PKCi significantly reduces K-ras
G12D-
induced formation of Nestin-positive intermediate. Pancreatic
acinar cells isolated from LSL-Kras and LSL-Kras;Prkci
f/f mice were
incubated with Ad-Cre and embedded in collagen. Nestin immunoflu-
orescence (green) was very low on day 1, and induced on day 3 of
explant culture in LSL-Kras but not LSL-Kras;Prkci
f/f cells. Cells were co-
stained with DAPI (blue). Scale bar, 25 mm.
doi:10.1371/journal.pone.0030509.g005
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chem), c-secretase inhibitor (Tocris), soybean trypsin inhibitor
(USB), Waymouth MB medium, Dexamethasone (Sigma Chem-
icals), Rat tail collagen (BD Biosciences), collagenase P (Roche), X-
gal stock solution, Stain Base Solution and b-gal fixative
(Millipore), adeno-null (control) virus, adeno-Cre virus and
adeno-Cre-GFP virus (Vector BioLabs), aurothiomalate (Myo-
chrysine; Taylor Pharmaceuticals).
Mice. LSL-Kras
G12D (LSL-Kras) mice were obtained from the
NCI Mouse Repository (MMHCC), Rosa26 reporter (R26R) mice
were obtained from Jackson Labs and P48-Cre mice were a gift
from Dr. Pinku Mukherjee, University of North Carolina. LSL-
Kras mice were crossed with P48-Cre mice to generate P48-Cre;LSL-
Kras mice, as described by others. [2,4] Floxed PKCi (Prkci
f/f) mice
(previously called floxed PKC-l or PKCl
fl/fl mice) have been
previously described. [18,34,40] In some experiments, previously
described LSL-Kras;Prkci
f/f mice were utilized. [16] Recombination
of floxed alleles was characterized by PCR analysis of genomic
DNA (see Table S2 for PCR primer sequences).
Immunohistochemistry. Mouse tissues were processed for
immunohistochemistry as described previously. [41] PKCi
staining was visualized using Mouse-on-mouse HRP-Polymer kit
(Biocare) and CK-19 was visualized using Rat-on-mouse HRP
Polymer kit (Biocare). Images were captured and analyzed using
Aperio and Spectrum software.
Pancreatic acinar cell explant cultures
Mouse pancreatic acinar cells were isolated and cultured as
described. [11,14] Additional details can be found in Supporting
Materials and Methods S1.
Adenoviral infection and beta-galactosidase activity
Pancreatic acinar cells were infected with adeno-Cre, adeno-
Cre-GFP or a control, adeno-null virus (50:1 multiplicity of
Figure 6. Inhibition of PKCi significantly reduces activation of Notch signaling. A, B) Pancreatic acinar cells isolated from LSL-Kras and LSL-
Kras;Prkci
f/f mice were incubated with Ad-Cre and embedded in collagen matrix. Pancreatic explants were stained for A) cleaved Notch1 (green) and
B) Hes1 (green). Cultures were co-stained with DAPI (blue). Scale bar, 25 mm. C)Ac-secretase inhibitor significantly reduced K-ras
G12D-induced
metaplastic duct formation. Pancreatic acinar cells isolated from LSL-Kras mice were incubated with Ad-Cre and embedded in collagen 6 1 mML -
685,458. Quantitative analysis of duct formation is plotted. Plot is representative of two independent experiments. Bars=mean 6 SEM and *P,.05.
doi:10.1371/journal.pone.0030509.g006
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15 minutes for the first hour. Thereafter, the cells were embedded
in collagen matrix and grown for up to 7 days in explant culture.
For detection of b-gal activity, collagen explants were washed,
fixed and stained in X-gal overnight at 37uC. [11] Transduction
efficiency calculation is described in Supporting Materials and
Methods S1.
Immunofluorescence
Pancreatic explant cultures were fixed and labeled with
fluorescent antibodies as described. [11,14] Fluorescent images
were captured on a Zeiss LSM-510 Meta confocal microscope and
bright field and GFP images were captured on an Olympus IX71/
IX51 inverted microscope.
Statistical analysis
Unless otherwise noted, two-way Analysis of Variance (AN-
OVA) was used to evaluate the statistical significance of the
difference between groups, and a P value,.05 was considered
statistically significant.
Supporting Information
Figure S1 PKCi expression and subcellular distribution
in mPanINs. PKCi expression detected by IHC (brown) in
pancreata isolated from P48-Cre;LSL-Kras mice. Representative
images of mPanINs and invasive adenocarcinoma are shown.
Scale bar, 50 mm.
(TIF)
Figure S2 Characterization of TGF-a-induced ADM. A)
Pancreatic acinar cells isolated from WT mice were embedded in
collagen and treated with TGF-a. Scale bars, 100 mm. B) Co-
immunofluorescence of the acinar cell marker amylase (red) and
the ductal cell marker CK-19 (green) in day 1 and day 7 explant
cultures. DAPI (blue) co-staining is shown. Scale bar, 25 mm.
(TIF)
Figure S3 No effect of Cre-recombinase on TGF-a-
induced ADM. A) PCR analysis of genomic DNA detects
recombined floxed Prkci allele in Ad-Cre-treated, but not control
adenovirus-(Ad-null)-treated Prkci
f/f mouse pancreatic acinar cells.
See Table S2 for PCR primer sequences. B) Representative
bright field images of primary acinar cells from WT mice
incubated with Ad-Cre and embedded in collagen 6 TGF-a for
7 days. Scale bar, 200 mm. C) Pancreatic acinar cells were isolated
from R26R mice, incubated with Ad-null or Ad-Cre and
embedded in collagen 6 TGF-a for 7 days. b-galactosidase
staining indicates Ad-Cre-mediated recombination of the RO-
SA26R allele. Scale bar, 50 mm.
(TIF)
Figure S4 Characterization of K-ras
G12D-induced ADM.
A) PCR detection of recombined LSL-Kras allele in genomic DNA
Figure 7. MMP-7 is induced by K-ras
G12D and exogenous MMP-7 partially rescues ADM in PKCi-depleted pancreatic acinar cells.
Pancreatic acinar cells were isolated from LSL-Kras and LSL-Kras;Prkci
f/f mice, incubated with Ad-Cre and embedded in collagen. A) Pancreatic explants
were stained for MMP-7 (green) on day 1 and 3. Scale bar, 25 mm. B) Representative bright field images of Ad-Cre-infected cultures of LSL-Kras cells,
LSL-Kras;Prkci
f/f cells and LSL-Kras;Prkci
f/f cells incubated with 200 ng/ml active recombinant MMP-7 (rMMP-7). Arrows indicate restored metaplastic
duct formation in MMP-7-treated LSL-Kras;Prkci
f/f cultures. Scale bar, 200 mm. C) Quantitative analysis of duct formation in B). Bars=mean 6 SEM.
*P,.05 versus LSL-Kras; #P,.05 versus LSL-Kras and LSL-Kras;Prkci
f/f without rMMP-7. Plot is representative of two independent experiments.
doi:10.1371/journal.pone.0030509.g007
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Table S2 for PCR primer sequences. B) Representative image of
H&E stained, formalin-fixed, paraffin-embedded day 7 explant
culture of Ad-Cre-treated LSL-Kras cells. Note the single layer of
duct-like cells that surround the luminal structure is more easily
distinguished in fixed and sectioned explant culture. C) Co-
immunofluorescence of chymotrypsin (green) and carbonic
anhydrase II (red) in Ad-Cre-treated LSL-Kras on day 1 and 7.
DAPI (blue) staining is shown. D) Co-immunofluorescence of
PKCi (red) and CK-19 (green) in Ad-Cre-treated LSL-Kras on day
7. DAPI (blue) staining is shown. Scale bar, 50 mm.
(TIF)
Figure S5 Characterization of genetic and pharmaco-
logical inhibition of PKCi in primary acinar cells. A) Co-
immunofluorescence of PKCi (red) and CK-19 (green) in Ad-Cre-
treated LSL-Kras;Prkci
f/f cells in explant culture (day 7). DAPI (blue)
staining is shown. Scale bar, 50 mm. B) Representative bright field
and fluorescent images Adeno-Cre-GFP virus-treated LSL-Kras
and LSL-Kras;Prkci
f/f acinar cells in explant culture (day 6). GFP
expression demonstrates high viral efficiency as well as cell
viability. Scale bar, 200 mm. C) PCR detection of recombined
LSL-Kras and floxed Prkci alleles in genomic DNA of Ad-Cre-
treated pancreatic acinar cells, confirming Cre-recombinase
activity. See Table S2 for PCR primer sequences. D) Detection
of PKCi (red) in Ad-Cre-treated LSL-Kras acinar cells in explant
culture (day 7). Untreated (left panel) or+aurothiomalate (ATM;
right panel). PKCi expression is elevated in ATM-treated cells,
relative to non-K-ras
G12D–expressing acinar cells (panel A), but
cell-type-specific differences in PKCi subcellular distribution
makes determination of relative PKCi expression in K-ras
G12D–
induced cells 6 ATM (panel D), difficult. DAPI (blue) staining is
shown. Scale bar, 25 mm. E) mRNA was isolated from day 1 and 6
explant cultures of Ad-Cre virus-treated LSL-Kras acinar cells +/2
ATM and analyzed by qPCR for PKCi expression. Data is
presented relative to 18 S abundance and presented relative to
PKCi mRNA expression on day 1. Data presented is represen-
tative of two independent experiments.
(TIF)
Figure S6 Characterization of the relationship between
PKCi and MMP-7 in K-ras
G12D-mediated ADM. A) mRNA
was isolated from day 1 and 6 explant cultures of Ad-Cre virus-
treated LSL-Kras and LSL-Kras;Prkci
f/f acinar cells and analyzed by
qPCR for MMP-7 expression. Data is presented relative to 18 S
abundance (610
5) and is representative of two independent
experiments. B) Immunofluorescence of PKCi (red) in Ad-Cre-
treated LSL-Kras;Prkci
f/f cells plated with 200 ng/ml active
recombinant MMP-7 (rMMP-7) in explant culture (day 6). DAPI
(blue) staining is shown. Scale bar, 50 mm.
(TIF)
Table S1 Summary of antibodies used.
(DOC)
Table S2 Summary of PCR primers.
(DOC)
Materials and Methods S1
(DOC)
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